The first question from Senate Health Education Labor & Pensions Committee Chairman Lamar Alexander (R-Tenn.) during the committee’s Oct. 17 drug pricing hearing demonstrates the triumph of the pharmaceutical industry’s campaign to broaden the discussion around prices.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?